Related Experiment Video
Updated: May 16, 2026

09:18
Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
Published on: January 12, 2019
Innovative methods to assess upper limb strength and function in non-ambulant Duchenne patients
L Servais1, N Deconinck, A Moraux
1Institute of Myology, AP-HP, Groupe hospitalier La Pitié Salpétrière, Paris, France. l.servais@institut-myologie.org
Neuromuscular Disorders : NMD
|December 11, 2012
Summary
New tools accurately measure upper limb strength and function in non-ambulant individuals, particularly those with Duchenne muscular dystrophy. These reliable assessments aid in tracking disease progression and treatment effectiveness.
Area of Science:
- Neurology
- Rehabilitation Medicine
- Biomedical Engineering
Background:
- Assessing upper limb function in non-ambulant patients, especially those with Duchenne muscular dystrophy (DMD), presents significant challenges.
- Existing assessment tools may lack the precision needed to capture functional deficits in this population.
Purpose of the Study:
- To develop and validate novel tools for precise measurement of upper limb strength and repetitive movement capacity.
- To evaluate the feasibility and reliability of these new tools in non-ambulant individuals with DMD and healthy controls.
Main Methods:
- Designed and implemented MyoPinch, MyoGrip, MyoWrist, and MoviPlate for assessing pinch, grip, wrist, and repetitive finger/wrist movements.
- Assessed feasibility and reliability in 30 non-ambulant DMD patients and 30 age-matched controls.
- Compared results with established measures like Motor Function Measure, Tapping, and Brooke Upper Extremity Functional Rating Scale.
Main Results:
- MyoGrip, MyoPinch, and MoviPlate demonstrated high feasibility across tested upper limbs.
- Excellent reliability was observed for all tests in both patient and control groups, though MyoWrist was not feasible in patients with contractures.
- Motor capacity showed a decline correlated with time spent in a wheelchair and partially correlated with other clinical measures.
Conclusions:
- The validated panel of upper limb strength and function measures is suitable for Duchenne Muscular Dystrophy patients across a spectrum of weakness.
- These tools provide a reliable and feasible method for assessing upper limb function in non-ambulant populations.
- The findings support the use of these novel tools for monitoring disease progression and potentially evaluating interventions in DMD.

